Kurkijarvi Kalevi 4
4 · FIBROGEN INC · Filed Feb 19, 2021
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Kurkijarvi Kalevi
Director
Transactions
- Exercise/Conversion
Common Stock
2021-02-17$28.65/sh+6,000$171,900→ 39,100 total - Sale
Common Stock
2021-02-17$52.31/sh−5,156$269,710→ 33,944 total - Sale
Common Stock
2021-02-17$52.93/sh−844$44,673→ 33,100 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-17−6,000→ 6,000 totalExercise: $28.65Exp: 2027-06-07→ Common Stock (6,000 underlying)
Footnotes (4)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $51.76 to $52.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The shares were sold at prices ranging from $52.76 to $53.17. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Fully vested.